Transthyretin Amyloidosis Stocks List Ranked for

	Symbol	Grade	Name	% Change
	ABUS	D	Arbutus Biopharma Corporation	1.60
	NTLA	F	Intellia Therapeutics, Inc.	7.39

Related Industries: Biotechnology

Symbol	Grade	Name	Weight
ARKG	F	ARK Genomic Revolution Multi-Sector ETF	3.89
GNOM	F	Global X Genomics & Biotechnology ETF	3.23
ARKK	B	ARK Innovation ETF	2.09
HRTS	D	Tema Cardiovascular and Metabolic ETF	1.66
CANC	D	Tema Oncology ETF	1.58

Compare ETFs

Date	Stock	Title
Nov 19	NTLA	Intellia Therapeutics Announces Promising CRISPR Therapy Results
Nov 19	NTLA	ReCode to secure funds for cystic fibrosis gene correction treatments
Nov 19	NTLA	Intellia Therapeutics price target lowered to $70 from $80 at Wells Fargo
Nov 19	NTLA	Intellia Therapeutics' Gene Therapies Fall Short Of Breakthroughs (Rating Downgrade)
Nov 18	NTLA	Intellia’s gene editing therapy shows early potential in rare heart condition
Nov 18	NTLA	CRISPR therapy from Intellia may ameliorate rare heart disorder, data suggest
Nov 16	NTLA	Intellia Announces First Clinical Evidence from Ongoing Phase 1 Study that Nexiguran Ziclumeran (nex-z), an In Vivo CRISPR/Cas9-Based Gene Editing Therapy, May Favorably Impact Disease Progression in Transthyretin (ATTR) Amyloidosis
Nov 15	ABUS	Arbutus’ Imdusiran Achieves Functional Cure in cHBV Patients when Combined with a Short Course of Interferon
Nov 15	ABUS	Arbutus and Barinthus Bio Announce New Data from the IM-PROVE II Trial Showing that the Addition of Nivolumab Increased Rates of HBsAg Loss in People with Chronic Hepatitis B

Transthyretin Amyloidosis: Transthyretin Amyloidosis (ATTR) is a rare, progressive, and fatal genetic disorder caused by the buildup of abnormal proteins in the body's organs and tissues. The abnormal proteins, called amyloid, are made up of a protein called transthyretin (TTR). As the amyloid builds up, it can damage organs and tissues, leading to a variety of symptoms. Symptoms of ATTR can include peripheral neuropathy, autonomic neuropathy, cardiomyopathy, and carpal tunnel syndrome. Treatment options for ATTR include medications, lifestyle changes, and organ transplantation.